Published research issue reference

Biomedical Research, Rare Disease & Therapeutic Access

Biomedical discovery, clinical research, rare-disease pathways, regulatory review, affordability, and equitable access to diagnostics and therapies.

Category: Care, Health, Family & Social Infrastructure
Subcategory: Behavioral Health, Public Health & Biomedical Access
Publication basis: Site-owner authorization + deterministic machine validation
Verification basis: Workbook-authored fit, limitations, gaps, and provenance; deterministic validation and objective verification are not claimed

Compare in Finder Locate this issue in the Forest Open Atom

Published analytical model

Thirteen structured research dimensions

Authorization controls public access. Evidence fit, limitations, counterevidence, gaps, and follow-up actions retain their distinct meanings.

Issue-specific research, publication state, and continuing epistemic boundaries
Analysis dimension	Published issue-specific input	Publication state	Interpretation boundary
Definition and Scope	Assess access, quality, capacity, continuity and equity in health, mental health, substance-use, child-welfare, food, housing and family-support systems.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Measures and Signals	population need or condition prevalence/incidence; coverage and eligibility; provider/service availability and wait time; utilization, denial and continuity; quality, morbidity/mortality or recovery outcome; subgroup and geographic outcome gap. Denominator: Source-defined eligible, exposed, diagnosed or resident population; separate administrative users from total need. Cadence: Annual trend where available, plus monthly/quarterly operational measures for access and capacity.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Stakeholders and Authority	Patients, families, caregivers, children and youth, people with disabilities, providers, community organizations, insurers, public agencies, researchers and workers.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Systems and Distribution	Insurance and public benefits; provider networks and workforce; public-health surveillance; child welfare; housing and shelter; food assistance; crisis response; biomedical research.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Implementation	Measure need, eligibility, access, utilization, quality, outcomes and unmet need separately; preserve population, geography and program definitions.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Capital Pathways	Medicaid/Medicare, grants, provider reimbursement, workforce investment, housing and shelter, research funding, prevention and community-based services.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Risks	Administrative exclusion, provider shortages, institutionalization, data gaps, medical or family stigma, fragmented eligibility, weak continuity and inequitable research access.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Safeguards	Accessible enrollment, continuity of care, community-based services, quality and outcome monitoring, grievance and appeal rights, privacy and subgroup analysis.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Tensions and Tradeoffs	Universal access versus targeted eligibility; prevention versus acute care; family autonomy versus protective intervention; innovation versus affordability and evidence.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Values and Responsibilities	Health, care, family integrity, autonomy, safety, access, continuity, dignity and prevention.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Policy and Rulings	12 recorded source references; 2 ruling-orientation records	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Related Issues and Research Relationships	3 directed research relationships; routing proximity does not establish causation or intersectionality.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.
Method, Boundaries, and Provenance	Publication is authorized separately from evidence fit, confidence, verification-state labels, limitations, and unresolved research gaps.	Published · owner-authorized	Evidence fit, limitations, counterevidence, and follow-up actions remain descriptive metadata.

Data-aware visual suite

Structure, sources, and research routing

These visuals organize the published records; they do not generate causal findings or numeric trends.

Issue River

Question: Where does this issue sit in the taxonomy?

Care, Health, Family & Social Infrastructure → Behavioral Health, Public Health & Biomedical Access → Biomedical Research, Rare Disease & Therapeutic Access

Source/data state: Recorded issue hierarchy; not a relationship or causal claim

Text equivalent

Care, Health, Family & Social Infrastructure → Behavioral Health, Public Health & Biomedical Access → Biomedical Research, Rare Disease & Therapeutic Access Recorded issue hierarchy; not a relationship or causal claim

Lens Map

Question: Which systems and distributional dimensions require issue-specific testing?

Insurance and public benefits; provider networks and workforce; public-health surveillance; child welfare; housing and shelter; food assistance; crisis response; biomedical research. Patients, families, caregivers, children and youth, people with disabilities, providers, community organizations, insurers, public agencies, researchers and workers.

Source/data state: Published workbook-authored research frame

Text equivalent

Relationship Mini-Map

Question: Which directed research relationships originate here?

3 directed research relationships; routing proximity does not establish causation or intersectionality.

Source/data state: Three workbook-authored routing hypotheses

Text equivalent

3 directed research relationships; routing proximity does not establish causation or intersectionality. Three workbook-authored routing hypotheses

Source Record Thread

Question: Which recorded source references make up this issue packet?

12 recorded source references; 2 ruling-orientation records

Source/data state: Twelve workbook-aligned source records

Text equivalent

12 governed source references; 2 ruling-orientation records Twelve workbook-aligned source records

Tension Axis

Question: How are supporting and limiting material kept separate?

Universal access versus targeted eligibility; prevention versus acute care; family autonomy versus protective intervention; innovation versus affordability and evidence.

Source/data state: Confirmatory and limiting orientations remain distinct

Text equivalent

Universal access versus targeted eligibility; prevention versus acute care; family autonomy versus protective intervention; innovation versus affordability and evidence. Confirmatory and limiting orientations remain distinct

Trend Pulse

Question: What changed over time?

No comparable dated measure or time series is assigned. The published measure plan defines what to collect; one signal or tag is not a trend. Information request: intake:biomedical-research-rare-disease-and-therapeutic-access:measures-trends.

Source/data state: information request open

Related Issues and Research Relationships

Three directed routing hypotheses

Direction is preserved. Proximity is a routing heuristic, not proof of causation, legal equivalence, population similarity, priority, or intersectionality.

Research relationship · research_required

Public-Health Preparedness & Infectious Disease

Related category: Care, Health, Family & Social Infrastructure
Routing proximity: 0.3504 · weak routing proximity
Shared terms: disease
Shared sources: src:acf-child-welfare; src:cdc-data; src:clinicaltrials; src:cms-data; src:hrsa-data; src:hud-ahar; src:ilo-care-economy; src:nih-gard; src:samhsa-data; src:us-census-acs; src:usda-food-security; src:who-gho
Candidate mechanism: disease
Relationship type: candidate_shared_mechanism_or_comparator

Claim boundary: Proximity is a routing heuristic only. It does not establish intersectionality, similarity of affected populations, causal direction, legal equivalence or priority.

Next action: Form a pair-specific hypothesis; identify shared and distinct mechanisms, counterfactual, population, jurisdiction, time period, confirmatory evidence and counterevidence.

research-relationship:biomedical-research-rare-disease-and-therapeutic-access:public-health-preparedness-and-infectious-disease

Research relationship · research_required

Child Welfare, Foster Care & Youth Development

Related category: Care, Health, Family & Social Infrastructure
Routing proximity: 0.2492 · low routing proximity
Shared terms: None recorded
Shared sources: src:acf-child-welfare; src:cdc-data; src:clinicaltrials; src:cms-data; src:hrsa-data; src:hud-ahar; src:ilo-care-economy; src:nih-gard; src:samhsa-data; src:us-census-acs; src:usda-food-security
Candidate mechanism: shared institutional or evidence-source pathway
Relationship type: candidate_shared_mechanism_or_comparator

Claim boundary: Proximity is a routing heuristic only. It does not establish intersectionality, similarity of affected populations, causal direction, legal equivalence or priority.

Next action: Form a pair-specific hypothesis; identify shared and distinct mechanisms, counterfactual, population, jurisdiction, time period, confirmatory evidence and counterevidence.

research-relationship:biomedical-research-rare-disease-and-therapeutic-access:child-welfare-foster-care-and-youth-development

Research relationship · research_required

Mental Health Access & Crisis Systems

Related category: Care, Health, Family & Social Infrastructure
Routing proximity: 0.2492 · low routing proximity
Shared terms: None recorded
Shared sources: src:acf-child-welfare; src:cdc-data; src:clinicaltrials; src:cms-data; src:hrsa-data; src:hud-ahar; src:ilo-care-economy; src:nih-gard; src:samhsa-data; src:us-census-acs; src:usda-food-security
Candidate mechanism: shared institutional or evidence-source pathway
Relationship type: candidate_shared_mechanism_or_comparator

Claim boundary: Proximity is a routing heuristic only. It does not establish intersectionality, similarity of affected populations, causal direction, legal equivalence or priority.

Next action: Form a pair-specific hypothesis; identify shared and distinct mechanisms, counterfactual, population, jurisdiction, time period, confirmatory evidence and counterevidence.

research-relationship:biomedical-research-rare-disease-and-therapeutic-access:mental-health-access-and-crisis-systems

Policy and Rulings

Sources and mixed authority

All twelve source references and both ruling orientations are public. Fit labels characterize use; they do not control publication.

Issue source packet

official information portal

Genetic and Rare Diseases Information Center

Issuer: National Institutes of Health
Jurisdiction: United States/Global
As of / cadence: Current
Roles: authority; stakeholders; systems
Scope: Authoritative disease information and links to research and support resources.
Limitations: Disease summaries are not treatment recommendations and do not establish access or outcomes.

Open external source: Genetic and Rare Diseases Information Center

src:nih-gard · publication authorized; verification state: official_page_identified

official trial registry

ClinicalTrials.gov

Issuer: U.S. National Library of Medicine
Jurisdiction: Global
As of / cadence: Continuously updated
Roles: measures; implementation; systems
Scope: Registry of interventional and observational studies, locations and reported results.
Limitations: Registration does not guarantee quality, completion, publication or efficacy.

Open external source: ClinicalTrials.gov

src:clinicaltrials · publication authorized; verification state: official_page_identified

official administrative data portal

CMS Data

Issuer: Centers for Medicare & Medicaid Services
Jurisdiction: United States
As of / cadence: Continuously updated
Roles: measures; implementation; capital; authority
Scope: Coverage, utilization, payment, quality and provider datasets for major federal health programs.
Limitations: Claims and administrative files reflect covered services and program eligibility.

Open external source: CMS Data

src:cms-data · publication authorized; verification state: official_page_identified

official research and policy resource

ILO Care Economy

Issuer: International Labour Organization
Jurisdiction: Global
As of / cadence: Current
Roles: authority; measures; implementation; risks
Scope: Definitions, statistics and policy resources on paid and unpaid care work, care jobs and care infrastructure.
Limitations: Global policy syntheses require local legal, fiscal and labor-market validation.

Open external source: ILO Care Economy

src:ilo-care-economy · publication authorized; verification state: official_page_verified

official health data portal

CDC Data and Statistics

Issuer: Centers for Disease Control and Prevention
Jurisdiction: United States
As of / cadence: Continuously updated
Roles: measures; stakeholders; systems
Scope: National and subnational public-health surveillance and administrative data.
Limitations: Definitions, reporting completeness and timeliness vary by surveillance system.

Open external source: CDC Data and Statistics

src:cdc-data · publication authorized; verification state: official_page_identified

official survey and administrative data portal

SAMHSA Data

Issuer: Substance Abuse and Mental Health Services Administration
Jurisdiction: United States
As of / cadence: Continuously updated
Roles: measures; stakeholders; implementation
Scope: Survey and program data on mental health, substance use and treatment systems.
Limitations: Self-report and service-use measures do not capture all need or severity.

Open external source: SAMHSA Data

src:samhsa-data · publication authorized; verification state: official_page_identified

official data portal

HRSA Data Warehouse

Issuer: Health Resources and Services Administration
Jurisdiction: United States
As of / cadence: Continuously updated
Roles: measures; implementation; systems
Scope: Health-workforce, shortage-area and safety-net service data.
Limitations: Designated shortage areas and provider counts are proxies rather than direct patient outcomes.

Open external source: HRSA Data Warehouse

src:hrsa-data · publication authorized; verification state: official_page_identified

official administrative data and reports

Child Welfare Data and Research

Issuer: Administration for Children and Families, Children's Bureau
Jurisdiction: United States
As of / cadence: Annual/periodic
Roles: measures; implementation; stakeholders
Scope: Official child-welfare administrative data and research products.
Limitations: State reporting practices and system definitions vary.

Open external source: Child Welfare Data and Research

src:acf-child-welfare · publication authorized; verification state: official_page_identified

official survey analysis

Food Security in the U.S.

Issuer: U.S. Department of Agriculture, Economic Research Service
Jurisdiction: United States
As of / cadence: Annual
Roles: measures; stakeholders; systems
Scope: National household food-security measures and methodological documentation.
Limitations: Household food insecurity does not directly measure individual nutritional status.

Open external source: Food Security in the U.S.

src:usda-food-security · publication authorized; verification state: official_page_identified

official administrative estimate

Annual Homelessness Assessment Report and Point-in-Time Data

Issuer: U.S. Department of Housing and Urban Development
Jurisdiction: United States
As of / cadence: Annual
Roles: measures; stakeholders; implementation
Scope: Point-in-time and annual estimates of sheltered and unsheltered homelessness.
Limitations: Point-in-time counts are affected by local methods, weather and undercount.

Open external source: Annual Homelessness Assessment Report and Point-in-Time Data

src:hud-ahar · publication authorized; verification state: official_page_identified

official dataset

American Community Survey (ACS)

Issuer: U.S. Census Bureau
Jurisdiction: United States
As of / cadence: Annual
Roles: measures; stakeholders; systems
Scope: Population, household, housing, ancestry, language, disability, education, income and geographic estimates.
Limitations: Survey estimates have sampling error; small groups and small geographies may require pooled years.

Open external source: American Community Survey (ACS)

src:us-census-acs · publication authorized; verification state: official_page_identified

intergovernmental health data portal

Global Health Observatory

Issuer: World Health Organization
Jurisdiction: Global
As of / cadence: Continuously updated
Roles: measures; stakeholders; systems
Scope: Cross-country health indicators, estimates and metadata.
Limitations: Country reporting quality, modeled estimates and comparability vary.

Open external source: Global Health Observatory

src:who-gho · publication authorized; verification state: official_page_identified

Confirmatory

confirmatory · Strong analogue

Association for Molecular Pathology v. Myriad Genetics, Inc.

569 U.S. 576 · U.S. Supreme Court · United States · 2013

Naturally occurring DNA segments are products of nature and not patent eligible merely because isolated, while cDNA may be eligible.

Issue linkage: Association for Molecular Pathology v. Myriad Genetics, Inc. supports or supplies a protective rule relevant to Biomedical Research, Rare Disease & Therapeutic Access. Fit tier: Strong analogue. The placement must be used only within the holding and limitations recorded here.

Authority: U.S. Supreme Court · precedential.

Scope and limitations: Does not resolve every biotechnology patent, diagnostic, data-ownership or access question. This fit tier must not be described as controlling authority.

Verification-state description: authoritative_text_identified; pinpoint_and_currentness_review_required

Open authoritative source

intake:biomedical-research-rare-disease-and-therapeutic-access:rulings-confirmatory · published placement

Disconfirmatory / Limiting

disconfirmatory · Strong analogue

Mayo Collaborative Services v. Prometheus Laboratories, Inc.

566 U.S. 66 · U.S. Supreme Court · United States · 2012

Invalidated patent claims that effectively claimed natural laws with only conventional steps.

Issue linkage: Mayo Collaborative Services v. Prometheus Laboratories, Inc. rejects, narrows, limits, or supplies adverse authority relevant to Biomedical Research, Rare Disease & Therapeutic Access. Fit tier: Strong analogue. The placement must be used only within the holding and limitations recorded here.

Authority: U.S. Supreme Court · precedential.

Scope and limitations: Patent eligibility is distinct from clinical validity, data rights, research funding and access. This fit tier must not be described as controlling authority.

Verification-state description: authoritative_text_identified; pinpoint_and_currentness_review_required

Open authoritative source

intake:biomedical-research-rare-disease-and-therapeutic-access:rulings-disconfirmatory · published placement

Published content

What this release establishes

The workbook-authored scope, research framework, source metadata, ruling placements, and directed research relationships are publicly available under the controlling owner authorization.

Limits and follow-up

What remains epistemically open

Claim-specific quotation/data extraction, currentness check, and issue-level synthesis remain required before publication.
Numeric values and trend series have not been silently invented; they require research connector extraction and validation.
No relationship strength or causal direction is established; pair-specific evidence and counterevidence remain required.
Pinpoint quotation, subsequent-history/currentness review and jurisdiction-specific applicability remain open.
Exact quotations, source locators, currentness review and direct issue applicability remain required.
The tension framework is populated; empirical trade-off evidence and current jurisdiction-specific counterauthority remain required.

These are limitations and research actions, not content holds.

Delivery conditions

Implementation, capital, risk, and safeguards

Implementation

Measure need, eligibility, access, utilization, quality, outcomes and unmet need separately; preserve population, geography and program definitions.

Capital pathways

Medicaid/Medicare, grants, provider reimbursement, workforce investment, housing and shelter, research funding, prevention and community-based services.

Risks

Administrative exclusion, provider shortages, institutionalization, data gaps, medical or family stigma, fragmented eligibility, weak continuity and inequitable research access.

Safeguards

Accessible enrollment, continuity of care, community-based services, quality and outcome monitoring, grievance and appeal rights, privacy and subgroup analysis.

Tensions and tradeoffs

Universal access versus targeted eligibility; prevention versus acute care; family autonomy versus protective intervention; innovation versus affordability and evidence.

Values and responsibilities

Health, care, family integrity, autonomy, safety, access, continuity, dignity and prevention.

Data Intake

13 adjudicated records for this issue

Every original request is preserved and joined one-to-one to its published fulfillment. Missing source/ruling request rows were not synthesized.

Requests: 13
Published / cleared: 13
Content holds: 0
Issue sources: 12
Ruling orientations: 2
Research relationships: 3

Authorized request and fulfillment register for this issue
Request ID	Section	Priority	Original request	Published response	Recommended follow-up	Current publication state
`intake:biomedical-research-rare-disease-and-therapeutic-access:capital-fit`	capital-fit	P2	Establish funding and implementation fit for Biomedical Research, Rare Disease & Therapeutic Access.	Capital pathways: Medicaid/Medicare, grants, provider reimbursement, workforce investment, housing and shelter, research funding, prevention and community-based services. Record instrument, payer, intermediary, recipient, restriction, duration, risk allocation, beneficiary reach and observed outcome separately.	Query the funding and award sources in the issue packet; distinguish appropriations, obligations, outlays, grants, contracts, loans, guarantees, tax expenditures and private capital.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:definition-authority`	definition-authority	P1	Add authoritative definitions and scope boundaries for Biomedical Research, Rare Disease & Therapeutic Access.	research scope: Assess access, quality, capacity, continuity and equity in health, mental health, substance-use, child-welfare, food, housing and family-support systems. For Biomedical Research, Rare Disease & Therapeutic Access, treat the unit of analysis as a source-defined law, rule, institution, service, market, exposure, process or observed outcome. Do not infer a claim from category membership, identity, geography or association alone. Starting authorities: Genetic and Rare Diseases Information Center, ClinicalTrials.gov, CMS Data.	Extract the operative definition, jurisdiction, exclusions, legal/status hierarchy and date from the cited sources; store exact locators.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:implementation`	implementation	P2	Document supported implementation pathways for Biomedical Research, Rare Disease & Therapeutic Access.	Implementation approach: Measure need, eligibility, access, utilization, quality, outcomes and unmet need separately; preserve population, geography and program definitions. Operationally, create an issue-specific logic chain from authority and need through implementer, action, output, outcome, remedy and feedback.	Populate responsible authority, implementer, delivery channel, eligibility, process step, service standard, output, outcome, cost and failure mode.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:measures-trends`	measures-trends	P1	Assign dated measures or a comparable time series for Biomedical Research, Rare Disease & Therapeutic Access.	Measurement framework: population need or condition prevalence/incidence; coverage and eligibility; provider/service availability and wait time; utilization, denial and continuity; quality, morbidity/mortality or recovery outcome; subgroup and geographic outcome gap. Denominator: Source-defined eligible, exposed, diagnosed or resident population; separate administrative users from total need. Cadence: Annual trend where available, plus monthly/quarterly operational measures for access and capacity.	Extract a baseline, latest value and comparable time series for each feasible indicator; retain numerator, denominator, geography, subgroup, methodology and vintage.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:relationships`	relationships	P2	Add explicit supported relationship records for Biomedical Research, Rare Disease & Therapeutic Access where evidence warrants them.	Candidate research relationships: Public-Health Preparedness & Infectious Disease (0.35; disease); Child Welfare, Foster Care & Youth Development (0.25; shared institutional/source pathway); Mental Health Access & Crisis Systems (0.25; shared institutional/source pathway). These are routing hypotheses based on title/source proximity, not research intersectionality or causal findings.	For each candidate pair, test a named shared mechanism, direction, comparator, counterfactual, distinctiveness and independent source support.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:risks-safeguards`	risks-safeguards	P2	Document issue-specific risks, failure conditions, and safeguards for Biomedical Research, Rare Disease & Therapeutic Access.	Material risks: Administrative exclusion, provider shortages, institutionalization, data gaps, medical or family stigma, fragmented eligibility, weak continuity and inequitable research access. Required safeguards: Accessible enrollment, continuity of care, community-based services, quality and outcome monitoring, grievance and appeal rights, privacy and subgroup analysis.	Create one risk-control record per material risk with trigger, affected population, preventive control, detective control, remedy, owner and monitoring indicator.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:rulings-confirmatory`	rulings-confirmatory	P1	Acquire confirmatory rulings for Biomedical Research, Rare Disease & Therapeutic Access.	Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (U.S. Supreme Court, 2013). Naturally occurring DNA segments are products of nature and not patent eligible merely because isolated, while cDNA may be eligible. Association for Molecular Pathology v. Myriad Genetics, Inc. supports or supplies a protective rule relevant to Biomedical Research, Rare Disease & Therapeutic Access. Fit tier: Strong analogue. The placement must be used only within the holding and limitations recorded here.	Verify official text, current precedential status, later treatment, pinpoint holding, jurisdiction and exact issue-claim linkage; add lower-court or agency authorities where needed.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:rulings-disconfirmatory`	rulings-disconfirmatory	P1	Acquire disconfirmatory, limiting, adverse, or narrowing rulings for Biomedical Research, Rare Disease & Therapeutic Access.	Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (U.S. Supreme Court, 2012). Invalidated patent claims that effectively claimed natural laws with only conventional steps. Mayo Collaborative Services v. Prometheus Laboratories, Inc. rejects, narrows, limits, or supplies adverse authority relevant to Biomedical Research, Rare Disease & Therapeutic Access. Fit tier: Strong analogue. The placement must be used only within the holding and limitations recorded here.	Verify official text, current precedential status, later treatment, pinpoint holding, jurisdiction and exact issue-claim linkage; add lower-court or agency authorities where needed.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:sources-policy-rulings`	sources-policy-rulings	P1	Acquire sources, datasets, policy records, and rulings for Biomedical Research, Rare Disease & Therapeutic Access.	A 12-source issue packet has been assembled from the Source Registry. Confirmatory candidate: Association for Molecular Pathology v. Myriad Genetics, Inc. (Strong analogue); disconfirmatory/limiting candidate: Mayo Collaborative Services v. Prometheus Laboratories, Inc. (Strong analogue). Policy, data, implementation and adjudicatory sources remain separately typed.	Extract exact locators and claim linkages; perform legal currentness review; add jurisdiction-specific lower-court and agency material where the registry records a gap or analogue.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:stakeholder-authority`	stakeholder-authority	P2	Identify documented affected groups, institutional actors, and decision authority for Biomedical Research, Rare Disease & Therapeutic Access.	Stakeholder set: Patients, families, caregivers, children and youth, people with disabilities, providers, community organizations, insurers, public agencies, researchers and workers. Separate affected people, rights holders, duty bearers, funders, implementers, data holders, adjudicators, advocates and potential opposing interests.	Validate each stakeholder class from a cited source; record authority, interest, exposure, decision rights, accountability and conflict-of-interest.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:systems-differences`	systems-differences	P2	Source the systems and distributional differences material to Biomedical Research, Rare Disease & Therapeutic Access.	Systems map: Insurance and public benefits; provider networks and workforce; public-health surveillance; child welfare; housing and shelter; food assistance; crisis response; biomedical research. Compare legal regime, eligibility, administrative process, funding, delivery channel, data definition, geography and population before making cross-system claims.	Build a comparison matrix across jurisdictions and subgroups; record which dimensions are comparable, non-comparable or missing.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:tensions`	tensions	P2	Document issue-specific tensions or contrary evidence for Biomedical Research, Rare Disease & Therapeutic Access.	Material tensions: Universal access versus targeted eligibility; prevention versus acute care; family autonomy versus protective intervention; innovation versus affordability and evidence.. Limiting authority candidate: Mayo Collaborative Services v. Prometheus Laboratories, Inc. (Strong analogue).	Record each tension as competing claim A/claim B, affected stakeholders, legal/policy authority, empirical trade-off, boundary conditions and adjudication or decision rule.	Published · owner-authorized
`intake:biomedical-research-rare-disease-and-therapeutic-access:values-responsibilities`	values-responsibilities	P2	Document issue-specific values and institutional responsibilities for Biomedical Research, Rare Disease & Therapeutic Access.	Values and responsibilities: Health, care, family integrity, autonomy, safety, access, continuity, dignity and prevention. Translate these into explicit duties for government, institutions, funders, implementers, data stewards and affected-community governance.	Link each asserted value to a legal, policy or ethical authority and to a measurable institutional responsibility, safeguard and remedy.	Published · owner-authorized

Open this issue in Data Intake

Method, boundaries, and provenance

Stable issue ID: issue:biomedical-research-rare-disease-and-therapeutic-access
Canonical route: /issues/care-health-family-social-infrastructure/biomedical-research-rare-disease-and-therapeutic-access/
Workbook: issue-requests.v1.all-asks-research-fulfillment.xlsx
Workbook SHA-256: 5612488c2e4edd2b42eed7c8bd97bb26f12a709d88d23b7101ea2fb7e7bbbdca
Publication authorization: research-publication-clearance-2026-07-21
deterministic validation required: No
Objective verification claimed: No
Taxonomy version: 2026-07-21-universal-issue-expansion-v1
Correction path: Propose a correction

This material is research routing and source/ruling metadata, not legal advice. Candidate, fit, gap, limitation, confidence, and verification-state labels remain descriptive and queryable.

Biomedical Research, Rare Disease & Therapeutic Access

Thirteen structured research dimensions

Structure, sources, and research routing

Issue River

Lens Map

Relationship Mini-Map

Source Record Thread

Tension Axis

Trend Pulse

Three directed routing hypotheses

Sources and mixed authority

Issue source packet

Confirmatory

Disconfirmatory / Limiting

What this release establishes

What remains epistemically open

Implementation, capital, risk, and safeguards

Implementation

Capital pathways

Risks

Safeguards

Tensions and tradeoffs

Values and responsibilities

13 adjudicated records for this issue

Cross-Family Match Bridges